Inactive Instrument

Analyst Reco. Syneos Health, Inc.

Stocks

SYNH

US87166B1026

Biotechnology & Medical Research

Analyst Reco.

23-05-16	Mizuho Securities Adjusts Syneos Health Price Target to $43 From $38, Maintains Neutral Rating	MT
23-05-11	Evercore ISI Raises Syneos Health's Price Target to $43 From $38, In Line Rating Kept	MT
23-05-11	JPMorgan Upgrades Syneos Health to Neutral From Underweight, Raises Price Target to $43 From $28	MT
23-05-11	Jefferies Raises Syneos Health's Price Target to $43 From $38, Hold Rating Kept	MT
23-05-11	Morningstar Downgrades Syneos Health to Hold From Buy, Cuts Price Target to $43 From $55	MT
23-05-11	Deutsche Bank Downgrades Syneos Health to Hold From Buy, Adjusts Price Target to $43 From $51	MT
23-05-11	UBS Adjusts Syneos Health Price Target to $43 From $40, Maintains Neutral Rating	MT
23-05-11	Barclays Upgrades Syneos Health to Equalweight From Underweight, Adjusts Price Target to $43 From $37	MT
23-05-11	Baird Downgrades Syneos Health to Neutral From Outperform, Price Target is $43	MT
23-04-04	Barclays Adjusts Syneos Health Price Target to $37 From $45, Maintains Underweight Rating	MT
23-03-01	Barclays Adjusts Price Target on Syneos Health to $45 From $30, Maintains Underweight Rating	MT
23-02-27	UBS Adjusts Syneos Health's Price Target to $40 From $34, Maintains Neutral Rating	MT
23-02-17	Baird Adjusts Price Target on Syneos Health to $51 From $42, Maintains Outperform Rating	MT
23-02-13	JPMorgan Downgrades Syneos Health to Underweight From Neutral, Adjusts Price Target to $28 From $30	MT
23-01-13	Barclays Downgrades Syneos Health to Underweight From Overweight, Price target is $25	MT
22-12-14	Mizuho Downgrades Syneos Health to Neutral From Buy, Slashes Price Target to $38 From $66	MT
22-11-09	Deutsche Bank Adjusts Syneos Health Price Target to $51 From $77, Maintains Buy Rating	MT
22-11-08	UBS Adjusts Syneos Health Price Target to $34 From $68, Maintains Neutral Rating	MT
22-11-07	Baird Adjusts Price Target on Syneos Health to $42 From $80, Maintains Outperform Rating	MT
22-11-07	Citigroup Adjusts Price Target on Syneos Health to $30 From $55, Maintains Neutral Rating	MT
22-11-07	Barclays Adjusts Price Target on Syneos Health to $30 From $60, Maintains Overweight Rating	MT
22-10-18	JPMorgan Downgrades Syneos Health to Neutral From Overweight, Adjusts Price Target to $53 From $85	MT
22-10-12	Deutsche Bank Adjusts Syneos Health's Price Target to $77 From $99, Maintains Buy Rating	MT
22-10-12	Mizuho Securities Adjusts Syneos Health's Price Target to $66 From $87, Reiterates Buy Rating	MT
22-10-06	Barclays Adjusts Syneos Health's Price Target to $60 From $70, Reiterates Overweight Rating	MT